Prospective, Randomized, Double-Blind, Study to Evaluate the Eosinophils Activation Parameters and Phagocyte Function in Patients With Persistent Asthma Treated With Montelukast.
Phase of Trial: Phase IV
Latest Information Update: 17 Dec 2010
At a glance
- Drugs Montelukast (Primary)
- Indications Asthma
- Focus Pharmacodynamics
- 17 Dec 2010 Trial phase changed from III to IV as reported by ClinicalTrials.gov.
- 03 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Dec 2009 Planned end date changed from 1 Apr 2010 to 1 Dec 2009 as reported by ClinicalTrials.gov.